Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health. Juniper develops pharmaceutical products, including CRINONE 8% (progesterone gel), which is marketed by Actavis, Inc. in the United States and by Merck Serono S.A. in over 60 countries worldwide. The Company has in-house pharmaceutical development, clinical trial manufacturing, and analytical capabilities to advance an internal development pipeline, while also providing consultative services to its pharmaceutical industry customers. Juniper Pharmaceuticals and Juniper Pharma Services are trademarks of the Company in the United States and European Union. CRINONE is a trademark of Actavis, Inc. in the United States.